Detalles de la búsqueda
1.
Bridging personality dimensions and eating symptoms: A transdiagnostic network approach.
Eur Eat Disord Rev;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722045
2.
Mediators between sexual abuse and eating disorder severity: A comparative case-control study in treatment-naïve patients.
Eur Eat Disord Rev;
31(5): 629-642, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283532
3.
The role of insight, social rank, mindfulness and self-compassion in depression following first episode psychosis.
Clin Psychol Psychother;
30(6): 1393-1406, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438084
4.
Cognitive variables associated with depressive and anxiety symptoms in patients with cancer: A five-year follow-up study.
Psychooncology;
31(5): 798-805, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921574
5.
Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
BMC Psychiatry;
22(1): 99, 2022 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139809
6.
Exploring the structure of the GAD-7 scale in primary care patients with emotional disorders: A network analysis approach.
J Clin Psychol;
78(2): 283-297, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287885
7.
Transdiagnostic group cognitive behavioural therapy for emotional disorders in primary care: the results of the PsicAP randomized controlled trial.
Psychol Med;
: 1-13, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33550995
8.
Moderators and predictors of treatment outcome in transdiagnostic group cognitive-behavioral therapy for primary care patients with emotional disorders.
Depress Anxiety;
2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043853
9.
Cognitive factors related to distress in patients recently diagnosed with cancer.
Psychooncology;
28(10): 1987-1994, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31295771
10.
Effect of Reliable Recovery on Health Care Costs and Productivity Losses in Emotional Disorders.
Behav Ther;
55(3): 585-594, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38670670
11.
Comparing psychological versus pharmacological treatment in emotional disorders: A network analysis.
PLoS One;
19(4): e0301675, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568925
12.
Patterns of cognitive-emotional change after cognitive-behavioural treatment in emotional disorders: A 12-month longitudinal cluster analysis.
PLoS One;
19(5): e0301746, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713680
13.
Long-term depressive symptom trajectories and related baseline characteristics in primary care patients: Analysis of the PsicAP clinical trial.
Eur Psychiatry;
67(1): e32, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532731
14.
The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial.
Schizophr Bull;
50(2): 427-436, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261464
15.
Symptoms of emotional disorders and sociodemographic factors as moderators of dropout in psychological treatment: A meta-review.
Int J Clin Health Psychol;
23(4): 100379, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922928
16.
Variables Associated with Emotional Symptom Severity in Primary Care Patients: The Usefulness of a Logistic Regression Equation to Help Clinical Assessment and Treatment Decisions.
Span J Psychol;
26: e24, 2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37655522
17.
Worry, rumination and negative metacognitive beliefs as moderators of outcomes of Transdiagnostic group cognitive-behavioural therapy in emotional disorders.
J Affect Disord;
338: 349-357, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336250
18.
Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.
PLoS One;
18(3): e0283104, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928238
19.
Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?
Compr Psychiatry;
53(6): 701-5, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22206803
20.
Psychometric properties of the Mindful Attention Awareness Scale (MAAS) in a first-episode psychosis sample.
Psychol Assess;
34(2): 188-196, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34647762